Correlation Between Neuropace and Acutus Medical
Can any of the company-specific risk be diversified away by investing in both Neuropace and Acutus Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Acutus Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Acutus Medical, you can compare the effects of market volatilities on Neuropace and Acutus Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Acutus Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Acutus Medical.
Diversification Opportunities for Neuropace and Acutus Medical
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Neuropace and Acutus is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Acutus Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acutus Medical and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Acutus Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acutus Medical has no effect on the direction of Neuropace i.e., Neuropace and Acutus Medical go up and down completely randomly.
Pair Corralation between Neuropace and Acutus Medical
Given the investment horizon of 90 days Neuropace is expected to generate 1.67 times more return on investment than Acutus Medical. However, Neuropace is 1.67 times more volatile than Acutus Medical. It trades about 0.07 of its potential returns per unit of risk. Acutus Medical is currently generating about -0.36 per unit of risk. If you would invest 428.00 in Neuropace on August 28, 2024 and sell it today you would earn a total of 638.00 from holding Neuropace or generate 149.07% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 4.24% |
Values | Daily Returns |
Neuropace vs. Acutus Medical
Performance |
Timeline |
Neuropace |
Acutus Medical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Neuropace and Acutus Medical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neuropace and Acutus Medical
The main advantage of trading using opposite Neuropace and Acutus Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Acutus Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acutus Medical will offset losses from the drop in Acutus Medical's long position.Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
Acutus Medical vs. STRATA Skin Sciences | Acutus Medical vs. Axogen Inc | Acutus Medical vs. Ainos Inc | Acutus Medical vs. LENSAR Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |